Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Standardizing chronic graft-versus-host disease.

Koen van Besien1

  • 1University of Chicago, Department of Hematology & Oncology, Chicago, IL, USA. kvbesien@uchicago.edu

Future Oncology (London, England)
|August 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy.

Leukemia & lymphoma·2026
Same author

ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis.

Leukemia & lymphoma·2026
Same author

Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records.

EClinicalMedicine·2026
Same author

Serological pseudoprogression of multiple myeloma after treatment with teclistamab.

Leukemia & lymphoma·2025
Same author

Embarrassment of riches: which donor for allo-transplant?

Blood advances·2025
Same author

Outcomes of relapsed/refractory peripheral T-cell lymphoma in the modern era: impact of stem cell transplant and novel agents.

Leukemia & lymphoma·2025

Consensus criteria for chronic graft-versus-host disease (cGVHD) diagnosis, staging, and response assessment are proposed. These advancements aim to standardize cGVHD management and research, improving patient care.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Chronic graft-versus-host disease (cGVHD) is a significant complication following allogeneic transplantation.
  • Current challenges include a lack of uniform diagnostic and staging criteria, hindering research progress.

Purpose of the Study:

  • To establish consensus criteria for the clinical and histological diagnosis of cGVHD.
  • To define standardized response assessments for cGVHD.
  • To provide recommendations for biomarker studies, supportive care, and clinical trial design in cGVHD.

Main Methods:

  • A consensus group convened to review existing literature and propose standardized criteria.
  • The consensus covered clinical and histological diagnoses, response assessment, biomarker evaluation, ancillary management, and study design.

Related Experiment Videos

Main Results:

  • Consensus criteria for diagnosis, staging, and response assessment of cGVHD were proposed.
  • Recommendations were formulated for biomarker research, supportive care, and future clinical study designs.

Conclusions:

  • The proposed consensus criteria are expected to significantly improve the standardization of cGVHD diagnosis and management.
  • These advancements are poised to profoundly alter the landscape of cGVHD research and patient care.